Marketa J.
- Country
- Norway
- Department
- Department of Opthalmology
Research Overview
Data & Insights
Has run more than one trial at 0 of 5 partner sites.
Specializations
Neuro‑oncology
Research on aggressive primary brain tumors, emphasizing survival outcomes in glioblastoma.
- Adjunct valganciclovir therapy for glioblastoma
- Targeted agents for rare brain malignancies
Efforts aim to improve median overall survival after surgical resection.
Oncology – Rare Cancers
Study of repurposed targeted therapies for hard‑to‑treat cancer subtypes.
- Precision medicine approaches
- Drug repurposing strategies
Focus on anti‑tumour activity and safety profiling.
Ophthalmology
Investigation of immunomodulatory treatment for active thyroid eye disease.
- Sirolimus versus corticosteroids
- Health‑related quality of life assessment
Aim to reduce treatment burden and side effects.
Endocrinology
Evaluation of hormone replacement regimens for primary adrenal insufficiency.
- Plenadren versus conventional cortisone
- Long‑term quality of life monitoring
Comparison of long‑term outcomes.
Infectious Diseases
Assessment of antibiotic stewardship in viral respiratory tract infection.
- Discontinuation of antibiotics
- Safety and non‑inferiority outcomes
Supports evidence‑based antimicrobial use.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.